Article
Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in GALNT3 Gene: Experience from Southern Turkey
Journal of clinical research in pediatric endocrinology - 20 Feb 2019
Kışla Ekinci Rabia Miray, Gürbüz Fatih, Balcı Sibel, Bişgin Atıl, Taştan Mehmet, Yüksel Bilgin, Yılmaz Mustafa
Abstract excerpt
Inactivating autosomal recessive mutations in fibroblast growth factor 23 (FGF23), klotho (KL) and polypeptide N-acetylgalactosaminotransferase 3 (GALNT3) genes lead to a rare disorder, hyperphosphatemic familial tumoral calcinosis (HFTC). Patients with HFTC present with hyperphosphatemia and tumor like soft tissue calcifications. Although 78% of patients develop their first symptoms between the ages of 2-13...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
